Scott W Roberts

Years Active: 2022-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Mark Klitgaard Nøhr, Shaik Rizwan Waheed, Rasmus Juul Kildemoes, Vibeke Hatorp, Tine Aggerholm Bækdal, Charlotte Lindorff Adrian, Lars Peter Korsholm, Eva Lisby Arp-Hansen, Helle Holst, Scott W Roberts
A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous Injection. The AAPS journal 26 (5) (2024)
Scott W Roberts, Tara Laura Brandt Elvang, Laila Syed, Marianne Bork Samuelsen, Eva Lisby Arp-Hansen, Henrik Kim Nielsen, Ida Katrine Lund, Dorte Lunøe Dünweber, Nicolai Listov-Saabye, Dorte Bjørn-Larsen, Anette Hjelmsmark, Tue Anker Mikkelsen
Correction: Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies. Therapeutic innovation & regulatory science (2022)
Scott W Roberts, Tara Laura Brandt Elvang, Laila Syed, Marianne Bork Samuelsen, Eva Lisby Arp-Hansen, Henrik Kim Nielsen, Ida Katrine Lund, Dorte Lunøe Dünweber, Nicolai Listov-Saabye, Dorte Bjørn-Larsen, Anette Hjelmsmark, Tue Anker Mikkelsen
Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies. Therapeutic innovation & regulatory science (2022)

Scott W Roberts.css-eqlu8i{font-size:small;padding-left:4px;}